nature.com search

Loading Filters

Showing 1–23 of 23 results

Loading Filters

Research | 7 October 2020 | Open
PET amyloid in normal aging: direct comparison of visual and automatic processing methods
Scientific Reports 10 , 1–8

Rights & permissionsfor article PET amyloid in normal aging: direct comparison of visual and automatic processing methods . Opens in a new window.
Amendments and Corrections | 15 July 2003 | Open
Erratum: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
- J-L Boulay
- , G Mild
- , A Lowy
- , J Reuter
- , M Lagrange
- , L Terracciano
- , U Laffer
- , R Herrmann
- & C Rochlitz
British Journal of Cancer 89 , 422–422

Rights & permissionsfor article Erratum: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer . Opens in a new window.
Research | 20 February 2017 | Open
Effects of fetal exposure to high-fat diet or maternal hyperglycemia on L-arginine and nitric oxide metabolism in lung
- C Grasemann
- , R Herrmann
- , J Starschinova
- , M Gertsen
- , M R Palmert
- & H Grasemann
Nutrition & Diabetes 7 , e244–e244

Rights & permissionsfor article Effects of fetal exposure to high-fat diet or maternal hyperglycemia on L-arginine and nitric oxide metabolism in lung . Opens in a new window.
Research | 16 October 2013
A critical pathway for the management of elderly inpatients with malnutrition: effects on serum insulin-like growth factor-I
- A Trombetti
- , J Cheseaux
- , F R Herrmann
- & R Rizzoli
European Journal of Clinical Nutrition 67 , 1175–1181

Rights & permissionsfor article A critical pathway for the management of elderly inpatients with malnutrition: effects on serum insulin-like growth factor-I . Opens in a new window.
Research | 21 March 2005
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation
- A Spencer
- , N Horvath
- , J Gibson
- , H M Prince
- , R Herrmann
- , J Bashford
- , D Joske
- , A Grigg
- , J McKendrick
- , I Prosser
- , R Lowenthal
- , S Deveridge
- & K Taylor
Bone Marrow Transplantation 35 , 971–977

Rights & permissionsfor article Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation . Opens in a new window.
Research | 28 January 2003
Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective
- M J Bargetzi
- , J Passweg
- , E Baertschi
- , A Schoenenberger
- , C Gwerder
- , A Tichelli
- , J Burger
- , W Mingrone
- , R Herrmann
- , A Gratwohl
- & M Wernli
Bone Marrow Transplantation 31 , 99–103

Rights & permissionsfor article Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective . Opens in a new window.
1 November 2010
113 The Apoptotic Effect of Propofol in Immature Rat Brain and Possible Neuroprotection by Erythropoietin
- C Pantazis
- , I Bendix
- , R Herrmann
- , T Karen
- , G Schlager
- , M Keller
- & U Felderhoff-Mueser
Pediatric Research 68 , 60–60

Rights & permissionsfor article 113 The Apoptotic Effect of Propofol in Immature Rat Brain and Possible Neuroprotection by Erythropoietin . Opens in a new window.
Research | 18 December 1965
Immunogenic Activity of Lipids of M. tuberculosis
- B. STÖSS
- & R. HERRMANN
Nature 208 , 1224–1224

Rights & permissionsfor article Immunogenic Activity of Lipids of M. tuberculosis . Opens in a new window.
1 November 2011
Evaluation of the Role of Ceacam1 in the Developing Neonatal Brain and its Impact on Encephalopathy of Prematurity
- S Prager
- , B B Singer
- , M Keller
- , I Bendix
- , G W Schlager
- , M Sifringer
- , R Herrmann
- , H Jastrow
- , S Ergün
- & U Felderhoff-Müser
Pediatric Research 70 , 201–201

Rights & permissionsfor article Evaluation of the Role of Ceacam1 in the Developing Neonatal Brain and its Impact on Encephalopathy of Prematurity . Opens in a new window.
1 September 1993
Molecular alterations in a patient with Turcot's syndrome
- CF Rochlitz
- , I Heide
- , E de Kant
- , A Neubauer
- , CA Schmidt
- , P Neuhaus
- , D Huhn
- & R Herrmann
British Journal of Cancer 68 , 519–523

Rights & permissionsfor article Molecular alterations in a patient with Turcot's syndrome . Opens in a new window.
3 September 2002 | Open
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
- J-L Boulay
- , G Mild
- , A Lowy
- , J Reuter
- , M Lagrange
- , L Terracciano
- , U Laffer
- , R Herrmann
- & C Rochlitz
British Journal of Cancer 87 , 630–634

Rights & permissionsfor article SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer . Opens in a new window.
Research | 3 April 2000
Treatment of solid tumors following allogeneic bone marrow transplantation
- G Favre-Schmuziger
- , S Hofer
- , J Passweg
- , A Tichelli
- , T Hoffmann
- , B Speck
- , R Herrmann
- & A Gratwohl
Bone Marrow Transplantation 25 , 895–898

Rights & permissionsfor article Treatment of solid tumors following allogeneic bone marrow transplantation . Opens in a new window.
28 September 2010 | Open
Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy
- J Bernhard
- , D Dietrich
- , B Glimelius
- , V Hess
- , G Bodoky
- , W Scheithauer
- & R Herrmann
British Journal of Cancer 103 , 1318–1324

Rights & permissionsfor article Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy . Opens in a new window.
10 February 2003 | Open
Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer
- C Mamot
- , G Mild
- , J Reuter
- , U Laffer
- , U Metzger
- , L Terracciano
- , J-L Boulay
- , R Herrmann
- & C Rochlitz
British Journal of Cancer 88 , 420–423

Rights & permissionsfor article Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer . Opens in a new window.
1 February 2007
The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders
- E Hammond
- , K Shaw
- & R Herrmann
Leukemia 21 , 815–816

Rights & permissionsfor article The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders . Opens in a new window.
1 February 2007
“The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders”, by El Housni et al.
- E Hammond
- , K Shaw
- & R Herrmann
Leukemia 21 , 817–818

Rights & permissionsfor article “The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders”, by El Housni et al. . Opens in a new window.
9 September 1999
Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)
- C Rochlitz
- , A Lohri
- , M Bacchi
- , M Schmidt
- , S Nagel
- , M Fopp
- , MF Fey
- , R Herrmann
- & A Neubauer
Leukemia 13 , 1352–1358

Rights & permissionsfor article Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK) . Opens in a new window.
1 November 2011
Impact of Experimental Neonatal Propofol Anaesthesia on Neurodevelopmental Short- and Long-Term Outcome
- G W Schlager
- , T Karen
- , I Bendix
- , M Sifringer
- , R Herrmann
- , C Pantazis
- , S Prager
- , M Keller
- & U Felderhoff-Müser
Pediatric Research 70 , 31–31

Rights & permissionsfor article Impact of Experimental Neonatal Propofol Anaesthesia on Neurodevelopmental Short- and Long-Term Outcome . Opens in a new window.
Correspondence | 7 January 2011
NOX-4 is expressed in thickened pulmonary arteries in idiopathic pulmonary fibrosis
Nature Medicine 17 , 31–32

Rights & permissionsfor article NOX-4 is expressed in thickened pulmonary arteries in idiopathic pulmonary fibrosis . Opens in a new window.
10 October 2006 | Open
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
- S Leyvraz
- , R Herrmann
- , L Guillou
- , H P Honegger
- , A Christinat
- , M F Fey
- , C Sessa
- , M Wernli
- , T Cerny
- , D Dietrich
- & B Pestalozzi
British Journal of Cancer 95 , 1342–1347

Rights & permissionsfor article Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies . Opens in a new window.
Research | 8 February 2019 | Open
Effect of the Great Recession on regional mortality trends in Europe
Nature Communications 10 , 1–9

Rights & permissionsfor article Effect of the Great Recession on regional mortality trends in Europe . Opens in a new window.
Research | 15 August 2017 | Open
Decreased NOX2 expression in the brain of patients with bipolar disorder: association with valproic acid prescription and substance abuse
- T Seredenina
- , S Sorce
- , F R Herrmann
- , X-J Ma Mulone
- , O Plastre
- , A Aguzzi
- , V Jaquet
- & K-H Krause
Translational Psychiatry 7 , e1206–e1206

Rights & permissionsfor article Decreased NOX2 expression in the brain of patients with bipolar disorder: association with valproic acid prescription and substance abuse . Opens in a new window.
14 November 2000 | Open
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings
- E Tartour
- , M Mehtali
- , X Sastre-Garau
- , I Joyeux
- , C Mathiot
- , J M Pleau
- , P Squiban
- , C Rochlitz
- , M Courtney
- , P Jantscheff
- , R Herrmann
- , P Pouillart
- , W H Fridman
- & T Dorval
British Journal of Cancer 83 , 1454–1461

Rights & permissionsfor article Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings . Opens in a new window.

Refine your results by…

Filters

Filter By:

PET amyloid in normal aging: direct comparison of visual and automatic processing methods

Erratum: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

Effects of fetal exposure to high-fat diet or maternal hyperglycemia on L-arginine and nitric oxide metabolism in lung

A critical pathway for the management of elderly inpatients with malnutrition: effects on serum insulin-like growth factor-I

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective

113 The Apoptotic Effect of Propofol in Immature Rat Brain and Possible Neuroprotection by Erythropoietin

Immunogenic Activity of Lipids of M. tuberculosis

Evaluation of the Role of Ceacam1 in the Developing Neonatal Brain and its Impact on Encephalopathy of Prematurity

Molecular alterations in a patient with Turcot's syndrome

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

Treatment of solid tumors following allogeneic bone marrow transplantation

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer

The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders

“The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders”, by El Housni et al.

Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK)

Impact of Experimental Neonatal Propofol Anaesthesia on Neurodevelopmental Short- and Long-Term Outcome

NOX-4 is expressed in thickened pulmonary arteries in idiopathic pulmonary fibrosis

Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies

Effect of the Great Recession on regional mortality trends in Europe

Decreased NOX2 expression in the brain of patients with bipolar disorder: association with valproic acid prescription and substance abuse

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters